Structure–Activity Relationships of Truncated C2- or C8-Substituted Adenosine Derivatives as Dual Acting A2Aand A3Adenosine Receptor Ligands

Journal of Medicinal Chemistry
2012.0

Abstract

Truncated N(6)-substituted-4'-oxo- and 4'-thioadenosine derivatives with C2 or C8 substitution were studied as dual acting A(2A) and A(3) adenosine receptor (AR) ligands. The lithiation-mediated stannyl transfer and palladium-catalyzed cross-coupling reactions were utilized for functionalization of the C2 position of 6-chloropurine nucleosides. An unsubstituted 6-amino group and a hydrophobic C2 substituent were required for high affinity at the hA(2A)AR, but hydrophobic C8 substitution abolished binding at the hA(2A)AR. However, most of synthesized compounds displayed medium to high binding affinity at the hA(3)AR, regardless of C2 or C8 substitution, and low efficacy in a functional cAMP assay. Several compounds tended to be full hA(2A)AR agonists. C2 substitution probed geometrically through hA(2A)AR docking was important for binding in order of hexynyl > hexenyl > hexanyl. Compound 4g was the most potent ligand acting dually as hA(2A)AR agonist and hA(3)AR antagonist, which might be useful for treatment of asthma or other inflammatory diseases.

Knowledge Graph

Similar Paper

Structure–Activity Relationships of Truncated C2- or C8-Substituted Adenosine Derivatives as Dual Acting A<sub>2A</sub>and A<sub>3</sub>Adenosine Receptor Ligands
Journal of Medicinal Chemistry 2012.0
C2,N6-Disubstituted adenosines: synthesis and structure-activity relationships
Journal of Medicinal Chemistry 1989.0
Synthesis and Biological Activity of New Potential Agonists for the Human Adenosine A<sub>2A</sub> Receptor
Journal of Medicinal Chemistry 2004.0
5‘-O-Alkyl Ethers of N,2-Substituted Adenosine Derivatives:  Partial Agonists for the Adenosine A<sub>1</sub> and A<sub>3</sub> Receptors
Journal of Medicinal Chemistry 2001.0
Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A2A adenosine receptor ligands
European Journal of Medicinal Chemistry 2019.0
2‘-C-Methyl Analogues of Selective Adenosine Receptor Agonists:  Synthesis and Binding Studies
Journal of Medicinal Chemistry 1998.0
N<sup>6</sup>,5‘-Disubstituted Adenosine Derivatives as Partial Agonists for the Human Adenosine A<sub>3</sub> Receptor
Journal of Medicinal Chemistry 1999.0
Xanthine functionalized congeners as potent ligands at A2-adenosine receptors
Journal of Medicinal Chemistry 1987.0
N9-Benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: Synthesis and structure–activity relationships at adenosine A1 and A2A receptors
Bioorganic &amp; Medicinal Chemistry 2007.0
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and Analogues as A<sub>2A</sub> Adenosine Receptor Antagonists. Design, Synthesis, and Pharmacological Characterization
Journal of Medicinal Chemistry 2005.0